Nippon Shinyaku Co., Ltd. (4516.T)

JPY 3735.0

(0.89%)

Total Liabilities Summary of Nippon Shinyaku Co., Ltd.

  • Nippon Shinyaku Co., Ltd.'s latest annual total liabilities in 2023 was 42.86 Billion JPY , up 3.25% from previous year.
  • Nippon Shinyaku Co., Ltd.'s latest quarterly total liabilities in 2024 Q1 was 38.36 Billion JPY , down -10.5% from previous quarter.
  • Nippon Shinyaku Co., Ltd. reported annual total liabilities of 41.52 Billion JPY in 2022, up 6.3% from previous year.
  • Nippon Shinyaku Co., Ltd. reported annual total liabilities of 39.05 Billion JPY in 2021, up 13.26% from previous year.
  • Nippon Shinyaku Co., Ltd. reported quarterly total liabilities of 34.61 Billion JPY for 2023 Q1, down -16.64% from previous quarter.
  • Nippon Shinyaku Co., Ltd. reported quarterly total liabilities of 42.86 Billion JPY for 2023 Q4, up 31.86% from previous quarter.

Annual Total Liabilities Chart of Nippon Shinyaku Co., Ltd. (2023 - 2004)

Historical Annual Total Liabilities of Nippon Shinyaku Co., Ltd. (2023 - 2004)

Year Total Liabilities Total Liabilities Growth
2023 42.86 Billion JPY 3.25%
2022 41.52 Billion JPY 6.3%
2021 39.05 Billion JPY 13.26%
2020 34.48 Billion JPY 17.87%
2019 29.25 Billion JPY -12.86%
2018 33.57 Billion JPY 3.29%
2017 32.5 Billion JPY -11.16%
2016 36.58 Billion JPY 12.21%
2015 32.6 Billion JPY 14.21%
2014 28.55 Billion JPY 14.19%
2013 25 Billion JPY 3.31%
2012 24.2 Billion JPY 11.34%
2011 21.73 Billion JPY 3.29%
2010 21.04 Billion JPY -9.31%
2009 23.2 Billion JPY 5.76%
2008 21.94 Billion JPY -16.14%
2007 26.16 Billion JPY -8.71%
2006 28.65 Billion JPY -2.35%
2005 29.34 Billion JPY 2.01%
2004 28.77 Billion JPY 0.0%

Peer Total Liabilities Comparison of Nippon Shinyaku Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Pharma Foods International Co., Ltd. 24.98 Billion JPY -71.554%
Takeda Pharmaceutical Company Limited 7834.78 Billion JPY 99.453%
Sumitomo Pharma Co., Ltd. 751.37 Billion JPY 94.295%
Shionogi & Co., Ltd. 164.35 Billion JPY 73.917%
Wakamoto Pharmaceutical Co.,Ltd. 3.39 Billion JPY -1162.688%
Kaken Pharmaceutical Co., Ltd. 27.86 Billion JPY -53.836%
Eisai Co., Ltd. 494.82 Billion JPY 91.337%
Morishita Jintan Co., Ltd. 5.04 Billion JPY -750.556%
Hisamitsu Pharmaceutical Co., Inc. 61.69 Billion JPY 30.515%
Mochida Pharmaceutical Co., Ltd. 30.83 Billion JPY -39.037%
Fuso Pharmaceutical Industries,Ltd. 39.79 Billion JPY -7.725%
Nippon Chemiphar Co., Ltd. 31.08 Billion JPY -37.91%
Tsumura & Co. 132.88 Billion JPY 67.741%
Kissei Pharmaceutical Co., Ltd. 39.79 Billion JPY -7.733%
Torii Pharmaceutical Co., Ltd. 13.29 Billion JPY -222.389%
Towa Pharmaceutical Co., Ltd. 274.75 Billion JPY 84.398%
Fuji Pharma Co., Ltd. 44.15 Billion JPY 2.921%
Zeria Pharmaceutical Co., Ltd. 70.7 Billion JPY 39.37%
KYORIN Holdings, Inc. 46.89 Billion JPY 8.583%
Taiko Pharmaceutical Co.,Ltd. 7 Billion JPY -512.138%
Daito Pharmaceutical Co.,Ltd. 25.43 Billion JPY -68.513%
SymBio Pharmaceuticals Limited 8.14 Billion JPY -426.496%
MedRx Co., Ltd 129 Million JPY -33131.008%
Mizuho Medy Co.,Ltd. 3.27 Billion JPY -1209.933%
Solasia Pharma K.K. 673 Million JPY -6269.688%
Modalis Therapeutics Corporation 645.5 Million JPY -6541.023%
ASKA Pharmaceutical Holdings Co.,Ltd. 31.38 Billion JPY -36.605%
Sawai Group Holdings Co., Ltd. 163.99 Billion JPY 73.86%
Cyfuse Biomedical K.K. 1.01 Billion JPY -4138.733%
Toho Holdings Co., Ltd. 523.98 Billion JPY 91.819%
Koa Shoji Holdings Co.,Ltd. 6.95 Billion JPY -516.598%